Therapeutics

Improve Your Prowess with Bandage Soft Lenses

A review of the use of these therapeutic aids for myriad patient conditions.
06/15/2022

​​Anti-TNF-α Successful in Noninfectious Uveitis Treatment

Adalimumab may top infliximab therapy and help guide management, study suggests.
10/18/2021

ARMOR Update: Ocular Antibiotic Resistance Still Prevalent

New data shows efficacy remains a problem, although resistance profiles haven’t changed much.
04/20/2020

Will Experimental Migraine Treatment Get the Green Light?

LED is being investigated as a non-pharmaceutical approach to pain management.
12/20/2019

Iris Implants Pose Ocular Health Risks

Study found more than 90% of eyes had at least one complication.
09/06/2019

Eye Patch Drug Delivery System Gets Good Marks

Painless and inexpensive, it could treat a host of eye conditions.
11/27/2018

MIGS: Getting Better All the Time

Studies show these techniques are evolving and leading to improved outcomes.
06/15/2018

Warding off the Blues

Blue light has its pros and cons. Here’s how to help your patients manage it for the best systemic and ocular outcomes.
06/15/2018

Anti-VEGF Doesn’t Affect the RPE, Study Says

Even 12 injections—one per week—did not cause premature aging in RPE.
05/30/2018

Managing Dry Eye for the Long Haul

Specific actions and lifestyle changes can optimize the treatment of this chronic disease and provide lasting relief.
05/15/2018

Upcoming Events

November 6, 2024

Showcasing Inflammation and IOP Control
Location: Prime 47
Presenters: Marc Bloomenstein, OD, and Nora Lee Cothran, OD
Time: 7:00pm CT

Sponsored by Bausch + Lomb

Register here

November 13, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Harry Boparai, OD, and Doug Katsev, MD
Webinar: 7:00pm PT

Sponsored by Bausch + Lomb

Register here

November 13, 2024

The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters: Jordana Fein, MD, and Julie Rodman, OD, MS, 
Webinar: 9:30pm ET


Sponsored by Apellis

Register here